BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24978662)

  • 21. Prospective European survey on atrial fibrillation ablation: clinical characteristics of patients and ablation strategies used in different countries.
    Themistoclakis S; Raviele A; China P; Pappone C; De Ponti R; Revishvili A; Aliot E; Kuck KH; Hoff PI; Shah D; Almendral J; Manolis AS; Chierchia GB; Oto A; Vatasescu RG; Sinkovec M; Cappato R;
    J Cardiovasc Electrophysiol; 2014 Oct; 25(10):1074-81. PubMed ID: 24891043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic drug therapy among patients presenting to emergency department with symptomatic atrial fibrillation - a prospective nationwide cohort.
    Penttilä T; Mäkynen H; Hartikainen J; Hyppölä H; Lauri T; Lehto M; Lund J; Raatikainen MJP;
    Scand J Trauma Resusc Emerg Med; 2017 Aug; 25(1):81. PubMed ID: 28810904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial fibrillation management, outcomes and predictors of stable disease in daily practice: prospective non-interventional study.
    Bosch RF; Kirch W; Theuer JD; Pittrow D; Kohlhaußen A; Willich SN; Bonnemeier H
    Int J Cardiol; 2013 Aug; 167(3):750-6. PubMed ID: 22475841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of atrial fibrillation.
    Watson T; Lip GY
    Herz; 2006 Dec; 31(9):849-56. PubMed ID: 17180647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
    Márk L; Erdej F; Dani G; Borbély M; Sziklai G; Nagy E; Hajdara I; Katona A
    Orv Hetil; 2004 May; 145(19):1001-6. PubMed ID: 15181735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Management of atrial fibrillation in France: the observational FACTUEL study].
    Mabo P; Leenhardt A; Jaillon P; Kacet S; Aubin F; Denjoy I; Le Heuzey JY
    Ann Cardiol Angeiol (Paris); 2009 Jun; 58(3):151-8. PubMed ID: 19477433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence, prevalence, and antithrombotic management of atrial fibrillation in elderly Germans.
    Ohlmeier C; Mikolajczyk R; Haverkamp W; Garbe E
    Europace; 2013 Oct; 15(10):1436-44. PubMed ID: 23487542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.
    Fang MC; Stafford RS; Ruskin JN; Singer DE
    Arch Intern Med; 2004 Jan; 164(1):55-60. PubMed ID: 14718322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Capucci A; Camm AJ; Olsson SB; Andresen D; Davies DW; Cobbe S; Breithardt G; Le Heuzey JY; Prins MH; Lévy S; Crijns HJ;
    Eur Heart J; 2005 Nov; 26(22):2422-34. PubMed ID: 16204266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of stroke in patients with atrial fibrillation: the role of new antiarrhythmic and antithrombotic drugs.
    Röther J; Crijns H
    Cerebrovasc Dis; 2010 Aug; 30(3):314-22. PubMed ID: 20664267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
    Brignole M; Menozzi C; Gasparini M; Bongiorni MG; Botto GL; Ometto R; Alboni P; Bruna C; Vincenti A; Verlato R;
    Eur Heart J; 2002 Jun; 23(11):892-900. PubMed ID: 12042011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
    Pappone C; Augello G; Sala S; Gugliotta F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Sora N; Greiss I; Santagostino A; LiVolsi L; Pappone N; Radinovic A; Manguso F; Santinelli V
    J Am Coll Cardiol; 2006 Dec; 48(11):2340-7. PubMed ID: 17161267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nonvalvular atrial fibrillation: thromboembolic risk assessment and therapy in a general practice population].
    Del Zotti F; Gottardi G; Frapporti G; Micchi A; Zanolla L
    G Ital Cardiol (Rome); 2010 Apr; 11(4):313-7. PubMed ID: 20677578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac remodeling with rhythm versus rate control strategies for atrial fibrillation in patients with heart failure: insights from the AF-CHF echocardiographic sub-study.
    Henrard V; Ducharme A; Khairy P; Gisbert A; Roy D; Levesque S; Talajic M; Thibault B; Racine N; White M; Guerra PG; Tardif JC;
    Int J Cardiol; 2013 May; 165(3):430-6. PubMed ID: 21917326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacotherapeutic decision-making for patients with atrial fibrillation.
    Kalus JS
    Am J Health Syst Pharm; 2010 May; 67(9 Suppl 5):S17-25. PubMed ID: 20410532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic management of atrial fibrillation: established and emerging options.
    Kalus JS
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S10-8. PubMed ID: 19678722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation.
    Madan N; Saksena S
    Am J Cardiol; 2004 Mar; 93(5):569-75. PubMed ID: 14996581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency, patient characteristics, treatment strategies, and resource usage of atrial fibrillation (from the Italian Survey of Atrial Fibrillation Management [ISAF] study).
    Zoni-Berisso M; Filippi A; Landolina M; Brignoli O; D'Ambrosio G; Maglia G; Grimaldi M; Ermini G
    Am J Cardiol; 2013 Mar; 111(5):705-11. PubMed ID: 23273528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
    Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM
    Card Electrophysiol Rev; 2003 Sep; 7(3):201-7. PubMed ID: 14739713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.